Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG and Etanercept in MDS
NCT00005853Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Dec 1999
- Primary completion
- Aug 2005
- Modality
- Antibody-Based Therapeutics, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin rabbit, etanercept in myelodysplastic syndrome (MDS), sponsored by Fred Hutchinson Cancer Center. Started Dec 1999; status: completed.
02
Drugs
antithymocyte globulin rabbitetanercept
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00005853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005853.